US Stock MarketDetailed Quotes

MEIP MEI Pharma

Watchlist
  • 3.1200
  • +0.0100+0.32%
Close May 21 16:00 ET
  • 3.0900
  • -0.0300-0.96%
Post 18:43 ET
20.79MMarket Cap0.80P/E (TTM)

MEI Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
Total revenue
0
0
647.96%65.3M
19.95%48.82M
-87.23%1.46M
-39.20%5.89M
176.66%32.74M
12.54%8.73M
16.96%40.7M
53.13%11.41M
Operating revenue
--0
--0
647.96%65.3M
19.95%48.82M
-87.23%1.46M
-39.20%5.89M
176.66%32.74M
12.54%8.73M
16.96%40.7M
53.13%11.41M
Cost of revenue
Gross profit
Operating expense
-55.89%9.83M
-49.89%11.93M
-62.83%10.02M
-26.34%85.58M
-54.59%12.54M
-28.69%22.29M
-19.17%23.81M
-3.28%26.95M
23.84%116.18M
20.42%27.61M
Selling and administrative expenses
-35.82%4.61M
-5.63%8.02M
-12.76%6.53M
8.48%33.13M
72.71%9.97M
-19.62%7.18M
7.19%8.5M
-5.35%7.49M
25.09%30.54M
-13.01%5.77M
-General and administrative expense
-35.82%4.61M
-5.63%8.02M
-12.76%6.53M
8.48%33.13M
72.71%9.97M
-19.62%7.18M
7.19%8.5M
-5.35%7.49M
25.09%30.54M
-13.01%5.77M
Research and development costs
-65.44%5.22M
-74.45%3.91M
-82.09%3.49M
-38.76%52.45M
-88.23%2.57M
-32.32%15.1M
-28.88%15.31M
-2.46%19.46M
23.41%85.64M
34.03%21.84M
Operating profit
40.03%-9.83M
-233.65%-11.93M
403.42%55.28M
51.30%-36.76M
31.59%-11.08M
23.97%-16.39M
150.64%8.93M
9.38%-18.22M
-24.92%-75.48M
-4.67%-16.2M
Net non-operating interest income expense
-26.23%706K
2.84%869K
127.92%1.09M
1,077.82%3.35M
416.02%1.06M
1,495.00%957K
7,581.82%845K
5,900.00%480K
-44.31%284K
1,484.62%206K
Non-operating interest income
-26.23%706K
2.84%869K
127.92%1.09M
1,077.82%3.35M
416.02%1.06M
1,495.00%957K
7,581.82%845K
5,900.00%480K
-44.31%284K
1,484.62%206K
Other net income (expense)
0.00%-4K
-100.41%-2K
-100.09%-1K
-92.38%1.58M
83.56%-12K
-100.03%-4K
-91.17%482K
-56.90%1.12M
11.49%20.75M
-101.03%-73K
Gain on sale of security
----
----
----
-92.28%1.6M
--0
----
-91.10%486K
-56.82%1.12M
14.51%20.75M
-100.95%-67K
Other non- operating income (expenses)
0.00%-4K
50.00%-2K
50.00%-1K
-266.67%-22K
---12K
---4K
---4K
---2K
-101.23%-6K
----
Income before tax
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
5.06%-16.62M
-31.83%-54.45M
-91.91%-16.06M
Income tax
Net income
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
5.06%-16.62M
-31.81%-54.45M
-91.73%-16.06M
Net income continuous Operations
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
5.06%-16.62M
-31.81%-54.45M
-91.73%-16.06M
Minority interest income
Net income attributable to the parent company
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
5.06%-16.62M
-31.81%-54.45M
-91.73%-16.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
5.06%-16.62M
-31.81%-54.45M
-91.73%-16.06M
Basic earnings per share
40.95%-1.37
-207.79%-1.66
439.76%8.46
45.37%-4.78
38.11%-1.51
-77.10%-2.32
177.00%1.54
22.19%-2.49
-18.24%-8.75
-52.50%-2.44
Diluted earnings per share
40.95%-1.37
-207.79%-1.66
439.76%8.46
52.15%-4.78
38.11%-1.51
-77.10%-2.32
155.00%1.54
30.83%-2.49
16.75%-9.99
6.15%-2.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022
Total revenue 00647.96%65.3M19.95%48.82M-87.23%1.46M-39.20%5.89M176.66%32.74M12.54%8.73M16.96%40.7M53.13%11.41M
Operating revenue --0--0647.96%65.3M19.95%48.82M-87.23%1.46M-39.20%5.89M176.66%32.74M12.54%8.73M16.96%40.7M53.13%11.41M
Cost of revenue
Gross profit
Operating expense -55.89%9.83M-49.89%11.93M-62.83%10.02M-26.34%85.58M-54.59%12.54M-28.69%22.29M-19.17%23.81M-3.28%26.95M23.84%116.18M20.42%27.61M
Selling and administrative expenses -35.82%4.61M-5.63%8.02M-12.76%6.53M8.48%33.13M72.71%9.97M-19.62%7.18M7.19%8.5M-5.35%7.49M25.09%30.54M-13.01%5.77M
-General and administrative expense -35.82%4.61M-5.63%8.02M-12.76%6.53M8.48%33.13M72.71%9.97M-19.62%7.18M7.19%8.5M-5.35%7.49M25.09%30.54M-13.01%5.77M
Research and development costs -65.44%5.22M-74.45%3.91M-82.09%3.49M-38.76%52.45M-88.23%2.57M-32.32%15.1M-28.88%15.31M-2.46%19.46M23.41%85.64M34.03%21.84M
Operating profit 40.03%-9.83M-233.65%-11.93M403.42%55.28M51.30%-36.76M31.59%-11.08M23.97%-16.39M150.64%8.93M9.38%-18.22M-24.92%-75.48M-4.67%-16.2M
Net non-operating interest income expense -26.23%706K2.84%869K127.92%1.09M1,077.82%3.35M416.02%1.06M1,495.00%957K7,581.82%845K5,900.00%480K-44.31%284K1,484.62%206K
Non-operating interest income -26.23%706K2.84%869K127.92%1.09M1,077.82%3.35M416.02%1.06M1,495.00%957K7,581.82%845K5,900.00%480K-44.31%284K1,484.62%206K
Other net income (expense) 0.00%-4K-100.41%-2K-100.09%-1K-92.38%1.58M83.56%-12K-100.03%-4K-91.17%482K-56.90%1.12M11.49%20.75M-101.03%-73K
Gain on sale of security -------------92.28%1.6M--0-----91.10%486K-56.82%1.12M14.51%20.75M-100.95%-67K
Other non- operating income (expenses) 0.00%-4K50.00%-2K50.00%-1K-266.67%-22K---12K---4K---4K---2K-101.23%-6K----
Income before tax 40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M5.06%-16.62M-31.83%-54.45M-91.91%-16.06M
Income tax
Net income 40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M5.06%-16.62M-31.81%-54.45M-91.73%-16.06M
Net income continuous Operations 40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M5.06%-16.62M-31.81%-54.45M-91.73%-16.06M
Minority interest income
Net income attributable to the parent company 40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M5.06%-16.62M-31.81%-54.45M-91.73%-16.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M5.06%-16.62M-31.81%-54.45M-91.73%-16.06M
Basic earnings per share 40.95%-1.37-207.79%-1.66439.76%8.4645.37%-4.7838.11%-1.51-77.10%-2.32177.00%1.5422.19%-2.49-18.24%-8.75-52.50%-2.44
Diluted earnings per share 40.95%-1.37-207.79%-1.66439.76%8.4652.15%-4.7838.11%-1.51-77.10%-2.32155.00%1.5430.83%-2.4916.75%-9.996.15%-2.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg